Research Analysts Offer Predictions for Teleflex Q4 Earnings

Teleflex Incorporated (NYSE:TFX - Free Report) - Research analysts at Zacks Research boosted their Q4 2025 earnings per share estimates for Teleflex in a research note issued to investors on Tuesday, April 29th. Zacks Research analyst R. Department now expects that the medical technology company will post earnings per share of $3.90 for the quarter, up from their previous estimate of $3.89. The consensus estimate for Teleflex's current full-year earnings is $13.98 per share. Zacks Research also issued estimates for Teleflex's Q4 2026 earnings at $3.74 EPS.

Several other analysts have also recently commented on the stock. Needham & Company LLC reaffirmed a "hold" rating on shares of Teleflex in a research note on Wednesday, March 12th. Raymond James lowered Teleflex from an "outperform" rating to a "market perform" rating in a research note on Friday, February 28th. Bank of America lowered Teleflex from a "neutral" rating to an "underperform" rating and decreased their price target for the stock from $235.00 to $140.00 in a research note on Tuesday, March 4th. Piper Sandler reaffirmed a "neutral" rating and set a $140.00 price objective (down previously from $255.00) on shares of Teleflex in a research note on Friday, February 28th. Finally, Truist Financial decreased their target price on shares of Teleflex from $149.00 to $140.00 and set a "hold" rating on the stock in a research report on Friday, April 11th. One investment analyst has rated the stock with a sell rating, nine have given a hold rating and two have assigned a buy rating to the company. According to MarketBeat, the stock presently has a consensus rating of "Hold" and an average target price of $167.25.

Teleflex Trading Up 0.3 %

Shares of NYSE:TFX traded up $0.43 during trading on Thursday, reaching $126.30. The stock had a trading volume of 753,291 shares, compared to its average volume of 638,279. The company has a quick ratio of 1.39, a current ratio of 2.42 and a debt-to-equity ratio of 0.37. The stock has a market cap of $5.86 billion, a P/E ratio of 25.11, a PEG ratio of 1.73 and a beta of 1.19. The business has a fifty day moving average price of $135.82 and a 200-day moving average price of $170.33. Teleflex has a fifty-two week low of $124.66 and a fifty-two week high of $249.91.

Teleflex (NYSE:TFX - Get Free Report) last posted its quarterly earnings data on Thursday, May 1st. The medical technology company reported $2.91 EPS for the quarter, topping analysts' consensus estimates of $2.88 by $0.03. The firm had revenue of $700.67 million during the quarter, compared to analysts' expectations of $699.37 million. Teleflex had a return on equity of 14.19% and a net margin of 7.85%. The firm's quarterly revenue was down 5.0% compared to the same quarter last year. During the same quarter last year, the business posted $3.21 EPS.

Institutional Investors Weigh In On Teleflex

Institutional investors have recently bought and sold shares of the business. Norges Bank purchased a new stake in Teleflex during the 4th quarter worth $100,328,000. Invesco Ltd. lifted its stake in shares of Teleflex by 48.1% during the fourth quarter. Invesco Ltd. now owns 1,068,593 shares of the medical technology company's stock worth $190,188,000 after purchasing an additional 347,003 shares in the last quarter. Diamond Hill Capital Management Inc. purchased a new stake in shares of Teleflex in the fourth quarter worth about $46,696,000. T. Rowe Price Investment Management Inc. grew its stake in shares of Teleflex by 4.4% in the fourth quarter. T. Rowe Price Investment Management Inc. now owns 6,173,121 shares of the medical technology company's stock valued at $1,098,693,000 after buying an additional 261,279 shares in the last quarter. Finally, Magnetar Financial LLC raised its holdings in shares of Teleflex by 105.2% during the 4th quarter. Magnetar Financial LLC now owns 421,340 shares of the medical technology company's stock valued at $74,990,000 after buying an additional 215,961 shares during the period. 95.62% of the stock is currently owned by hedge funds and other institutional investors.

Teleflex Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Monday, March 17th. Investors of record on Friday, March 7th were issued a $0.34 dividend. The ex-dividend date was Friday, March 7th. This represents a $1.36 annualized dividend and a yield of 1.08%. Teleflex's payout ratio is 95.77%.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.